Rheumatology advances in practice
Cardiovascular risk and lipid-lowering therapy in idiopathic inflammatory myopathies: a call for improved, disease-specific risk assessment.
Kimberly Loh, Emily Rose, Sarah Tansley
Published: 202610.1093/rap/rkaf141
No abstract available for this study.